Italia markets closed

AMGN Oct 2023 265.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,03+0,97 (+13,74%)
Al 12:46PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente7,06
Aperto7,35
Denaro7,90
Lettera8,05
Prezzo d'esercizio265,00
Scadenza2023-10-20
Min-Max giorno6,80 - 8,03
Contratto - Min-MaxN/D
Volume115
Open Interest3,46k
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery